Sandbox:Affan: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! colspan=" | ! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Surface oral lesions | ||
|- | |- | ||
! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ||
Line 11: | Line 11: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
!Microscopic | |||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
Line 22: | Line 23: | ||
| | | | ||
* Buccal and labial oral mucosa | * Buccal and labial oral mucosa | ||
| | |||
* Intracellular edema or vacuolization of Malpighian cells | |||
| | | | ||
|- | |- | ||
Line 33: | Line 36: | ||
* Buccal mucosa | * Buccal mucosa | ||
* Vermillion border of the lips | * Vermillion border of the lips | ||
| | |||
* Similar to normal sebaceous glands of skin | |||
* Lacks hair follicles and almost always lack ductal communication with surface | |||
| | | | ||
|- | |- | ||
Line 46: | Line 52: | ||
| | | | ||
* Dorsal/Lateral surface of the tongue | * Dorsal/Lateral surface of the tongue | ||
| | |||
| | | | ||
|- | |- | ||
Line 59: | Line 66: | ||
| | | | ||
* Dorsum of the tongue | * Dorsum of the tongue | ||
| | |||
| | | | ||
|- | |- | ||
Line 75: | Line 83: | ||
* Floor of the mouth | * Floor of the mouth | ||
* Palate | * Palate | ||
| | |||
| | | | ||
|- | |- | ||
Line 86: | Line 95: | ||
| | | | ||
* Buccal mucosa | * Buccal mucosa | ||
| | |||
| | | | ||
|- | |- | ||
Line 97: | Line 107: | ||
* Posterior buccal mucosa | * Posterior buccal mucosa | ||
* Gingival margin | * Gingival margin | ||
| | |||
| | | | ||
|- | |- | ||
Line 109: | Line 120: | ||
* Buccal mucosa | * Buccal mucosa | ||
* Limited to line of dental occlusion | * Limited to line of dental occlusion | ||
| | |||
| | | | ||
|- | |- | ||
Line 120: | Line 132: | ||
* Smoking | * Smoking | ||
* | * | ||
| | |||
| | | | ||
| | | | ||
Line 133: | Line 146: | ||
* Floor of mouth | * Floor of mouth | ||
* Ventral surface of tongue and the retromolar area | * Ventral surface of tongue and the retromolar area | ||
| | |||
| | | | ||
|- | |- | ||
Line 139: | Line 153: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
! | |||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Physiologic pigmentation | * Physiologic pigmentation | ||
| | |||
| | | | ||
| | | | ||
Line 151: | Line 167: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Ephelis | * Ephelis | ||
| | |||
| | | | ||
| | | | ||
Line 159: | Line 176: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Oral melanocytic macule | * Oral melanocytic macule | ||
| | |||
| | | | ||
| | | | ||
Line 167: | Line 185: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Melanocytic nevus | * Melanocytic nevus | ||
| | |||
| | | | ||
| | | | ||
Line 175: | Line 194: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Oral melanoacanthoma | * Oral melanoacanthoma | ||
| | |||
| | | | ||
| | | | ||
Line 183: | Line 203: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Smoker's melanosis | * Smoker's melanosis | ||
| | |||
| | | | ||
| | | | ||
Line 191: | Line 212: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Melanoma | * Melanoma | ||
| | |||
| | | | ||
| | | | ||
Line 199: | Line 221: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Kaposi sarcoma | * Kaposi sarcoma | ||
| | |||
| | | | ||
| | | | ||
Line 207: | Line 230: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Addison's disease | * Addison's disease | ||
| | |||
| | | | ||
| | | | ||
Line 215: | Line 239: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Peutz jeghers syndrome | * Peutz jeghers syndrome | ||
| | |||
| | | | ||
| | | | ||
Line 223: | Line 248: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Neurofibromatosis | * Neurofibromatosis | ||
| | |||
| | | | ||
| | | | ||
Line 232: | Line 258: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Polyostotic fibrous dysplasia | * Polyostotic fibrous dysplasia | ||
| | |||
| | | | ||
| | | | ||
Line 240: | Line 267: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Medication induced pigmentation | * Medication induced pigmentation | ||
| | |||
| | | | ||
| | | | ||
Line 248: | Line 276: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Amalgam tattoo | * Amalgam tattoo | ||
| | |||
| | | | ||
| | | | ||
Line 258: | Line 287: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |characterestic features | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |characterestic features | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! | |||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Infections]] | | rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Infections]] | ||
| | |||
| | | | ||
| | | | ||
Line 268: | Line 299: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 274: | Line 306: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 280: | Line 313: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 286: | Line 320: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 292: | Line 327: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 298: | Line 334: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 310: | Line 347: | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Autoimmune conditions]] | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Autoimmune conditions]] | ||
| | |||
| | | | ||
| | | | ||
Line 316: | Line 354: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 322: | Line 361: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 328: | Line 368: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 338: | Line 379: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 346: | Line 389: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 353: | Line 397: | ||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Idiopathic conditions]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Idiopathic conditions]] | ||
| | |||
| | | | ||
| | | | ||
Line 359: | Line 404: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 365: | Line 411: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 371: | Line 418: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 377: | Line 425: | ||
| | | | ||
|- | |- | ||
| | |||
| | | | ||
| | | |
Revision as of 15:02, 11 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Affan M.D.[2]
Surface oral lesions | |||||||
---|---|---|---|---|---|---|---|
Oral lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
White Lesions | Leukoedema |
|
|
|
|
||
Fordyce granules |
|
|
|
|
|||
Benign migratoy glossitis |
|
|
|
||||
Hairy tongue |
|
|
|
||||
Hairy leukoplakia |
White patches
|
|
|
||||
White sponge nevus |
|
|
|||||
Lichen Planus |
|
|
|
||||
Frictional hyperkeratosis |
|
|
|
||||
Leukoplakia |
|
|
|||||
Erythroplakia |
|
|
|
||||
Pigmented lesions | Characterestic features | Associated conditions | Location | Image | |||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
Vesicular/Ulcerative oral lesions | Symptoms | characterestic features | Associated conditions | Location | Image | ||
Infections | |||||||
Autoimmune conditions | |||||||
Idiopathic conditions | |||||||
Soft tissue oral lesions | ||||||
---|---|---|---|---|---|---|
Reactive lesions | Symptoms | Characterstic features | Associated conditions | Location | Image | |
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
Tumors | etiology | location | Clinical appearance | Gold standard/Diagnosis | Image | |
Benign tumors |
|
|||||
|
||||||
|
||||||
Malignant tumors |
|
|||||
|
||||||
|
||||||
|
||||||
Cysts |
|
|||||
|
||||||
|
||||||
|
||||||
|